نتایج جستجو برای: dipeptidyl peptidase 4

تعداد نتایج: 1310834  

Journal: :Clinical Medicine Insights: Endocrinology and Diabetes 2020

Journal: :Dermatology Reports 2023

Bullous pemphigoid (BP) is an autoimmune disease with a chronic relapsing course, predominantly affecting elderly people. Drugs are one of the possible triggers. A class antidiabetic drugs often associated development BP inhibitors dipeptidyl peptidase 4 (DPP-4 or gliptins), while less known association glucagon-like-peptide-1 (GLP-1) receptor agonists. We describe case caused by dulaglutide an...

2013
Junji Kozawa Tetsuhiro Kitamura Hitoshi Nishizawa Tetsuyuki Yasuda Norikazu Maeda Michio Otsuki Kohei Okita Hiromi Iwahashi Hideaki Kaneto Tohru Funahashi Akihisa Imagawa Iichiro Shimomura

AIMS/INTRODUCTION Recently, dipeptidyl peptidase-4 (DPP-4) inhibitors have become available in Japan. It has not yet been clarified what clinical parameters could discriminate DPP-4 inhibitor-effective patients from DPP-4 inhibitor-ineffective patients. MATERIALS AND METHODS We reviewed 33 consecutive patients with type 2 diabetes admitted to Osaka University Hospital for glycemic control. Al...

2017
Fumitaka Okajima Tomoko Nagamine Yuko Nakamura Naomi Hattori Hitoshi Sugihara Naoya Emoto

The efficacy of the administration of sodium-glucose co-transporter 2 inhibitor or the co-administration of sodium-glucose co-transporter 2 inhibitor and dipeptidyl peptidase-4 inhibitor to insulin therapy is not well known. A total of 58 patients with type 2 diabetes, admitted for glycemic control, were randomized to basal-bolus insulin therapy (BBT) alone or BBT plus 50 mg ipragliflozin and/o...

Journal: :Clinical science 2013
Usha Panchapakesan Amanda Mather Carol Pollock

Although there have been major advances in the understanding of the molecular mechanisms that contribute to the development of diabetic nephropathy, current best practice still leaves a significant treatment gap. The incidence of diabetes and associated nephropathy is increasing, with the main cause of mortality being related to cardiovascular causes. Novel therapies which are both 'cardio-rena...

2013
David Scott

Diabetes is the leading cause of chronic kidney disease, and the prevalence of both diseases is rising worldwide. Treatment of type 2 diabetes is difficult in patients with chronic kidney disease because most oral antidiabetic agents are affected by renal function and their use may be contraindicated in this patient population. Antidiabetic agents that can be used in patients with type 2 diabet...

2001
Stefan Brocke Andreas Steinbrecher Dirk Reinhold Laura Quigley Ameer Gado Nancy Tresser Leonid Izikson Ilona Born Jürgen Faust Klaus Neubert Roland Martin Siegfried Ansorge

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید